Trial site
Petah Tikva
- 13running trials
- 7closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- IgA nephropathy3 trials
- Prostate cancer3 trials
- Chronic myeloid leukaemia2 trials
- Coronary artery disease2 trials
- Familial hypercholesterolaemia2 trials
- Stroke2 trials
- Aortic stenosis1 trial
- Childhood cancers1 trial
- Chronic kidney disease1 trial
- Colorectal cancer1 trial
- Gastric and oesophageal cancer1 trial
- Glioblastoma1 trial
- and 6 more
- Phase
- Phase 311 trials
- Phase 26 trials
- Phase 2/31 trial
- Phase 41 trial
- Status
- Active, not recruiting8 trials
- Completed6 trials
- Recruiting5 trials
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals20 trials
Running trials
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVD
Active, not recruiting
Active, not recruiting
A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Prostate cancer2 recruiting
- Aortic stenosis1 recruiting
- IgA nephropathy1 recruiting
- Sjögren's disease1 recruiting
Closed trials
Terminated
Completed
Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients
Completed
Completed
Completed
Completed
Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026